Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
about
Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivoPreparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.
P2860
Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Tracer level radiochemistry to ...... eled cyclic RGD peptide dimer.
@en
Tracer level radiochemistry to clinical dose preparation of
@nl
type
label
Tracer level radiochemistry to ...... eled cyclic RGD peptide dimer.
@en
Tracer level radiochemistry to clinical dose preparation of
@nl
prefLabel
Tracer level radiochemistry to ...... eled cyclic RGD peptide dimer.
@en
Tracer level radiochemistry to clinical dose preparation of
@nl
P2093
P1476
Tracer level radiochemistry to ...... eled cyclic RGD peptide dimer.
@en
P2093
K V Vimalnath
M R A Pillai
Sudipta Chakraborty
P304
P356
10.1016/J.NUCMEDBIO.2013.05.011
P577
2013-07-11T00:00:00Z